Accelerate Diagnostics Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Accelerate Diagnostics (AXDX) Posts Smaller Q1 Loss
May 16, 2022 4:09 PM EDTAccelerate Diagnostics (NASDAQ: AXDX) reported Q1 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $3 million versus the consensus estimate of $2.9 million.
Net cash used in the quarter was $13.2 million, and the company ended the quarter with total... More
